My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 343

    1.

    Human ether-a-go-go-related gene K(+) channels regulate shedding of leukemia cell-derived microvesicles.

    Zheng F, Li J, Du W, Wang N, Li H, Huang S.

    Leuk Lymphoma. 2012 Mar 13. [Epub ahead of print]

    PMID:
    22292854
    [PubMed - as supplied by publisher]

    Related citations

    2.

    Chronic eosinophilic leukemia with erythroblastic proliferation and the rare translocation t(8;9)(p22;p24) with PCM1-JAK2 fusion gene: a distinct clinical, pathological and genetic entity with potential treatment target?

    Prochorec-Sobieszek M, Nasiłowska-Adamska B, Borg K, Kopeć I, Kos-Zakrzewska K, Juszczyński P, Warzocha K.

    Leuk Lymphoma. 2012 Mar 13. [Epub ahead of print] No abstract available.

    PMID:
    22288769
    [PubMed - as supplied by publisher]

    Related citations

    3.

    Phase 1 trial of linifanib (ABT-869) in patients with refractory or relapsed acute myeloid leukemia.

    Wang ES, Yee K, Koh LP, Hogge D, Enschede S, Carlson DM, Dudley M, Glaser K, McKeegan E, Albert DH, Li X, Pradhan R, Stock W.

    Leuk Lymphoma. 2012 Mar 1. [Epub ahead of print]

    PMID:
    22280537
    [PubMed - as supplied by publisher]

    Related citations

    4.

    Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia.

    de Viron E, Michaux L, Put N, Bontemps F, van den Neste E.

    Leuk Lymphoma. 2012 Mar 1. [Epub ahead of print]

    PMID:
    22280536
    [PubMed - as supplied by publisher]

    Related citations

    5.

    Specific p53 mutations do not impact results of alemtuzumab therapy among patients with chronic lymphocytic leukemia.

    Doubek M, Trbušek M, Malčíková J, Brychtová Y, Smardová J, Lochmanová J, Panovská A, Francová HS, Mráz M, Tichý B, Sebejová L, Navrkalová V, Plevová K, Kuglík P, Mayer J, Pospíšilová S.

    Leuk Lymphoma. 2012 Mar 1. [Epub ahead of print] No abstract available.

    PMID:
    22263566
    [PubMed - as supplied by publisher]

    Related citations

    6.

    Clinical impact of in vitro cellular drug resistance on childhood acute lymphoblastic leukemia in Taiwan.

    Chen SH, Yang CP, Jaing TH, Hung IJ, Shih LY, Ho PC, Lee WI, Huang JL.

    Leuk Lymphoma. 2012 Mar 1. [Epub ahead of print]

    PMID:
    22260162
    [PubMed - as supplied by publisher]

    Related citations

    7.

    Bcr-Abl dependent post-transcriptional activation of NME2 expression is a specific and common feature of chronic myeloid leukemia.

    Tschiedel S, Bach E, Jilo A, Wang SY, Lange T, Al-Ali HK, Vucinic V, Niederwieser D, Cross M.

    Leuk Lymphoma. 2012 Mar 1. [Epub ahead of print]

    PMID:
    22251158
    [PubMed - as supplied by publisher]

    Related citations

    8.

    Improving quality of life in chronic lymphocytic leukemia.

    Zent CS.

    Leuk Lymphoma. 2012 Feb 13. [Epub ahead of print] No abstract available.

    PMID:
    22242823
    [PubMed - as supplied by publisher]

    Related citations

    9.

    Reciprocal changes in regulatory T cells and Th17 helper cells induced by exercise in patients with chronic lymphocytic leukemia.

    Perry C, Herishanu Y, Hazan-Halevy I, Kay S, Bdolach N, Naparstek E, Polliack A, Grisaru D.

    Leuk Lymphoma. 2012 Feb 13. [Epub ahead of print] No abstract available.

    PMID:
    22242820
    [PubMed - as supplied by publisher]

    Related citations

    10.

    Priapism as an initial presentation of chronic lymphocytic leukemia.

    Gogia A, Sharma A, Raina V, Gupta R.

    Leuk Lymphoma. 2012 Feb 13. [Epub ahead of print] No abstract available.

    PMID:
    22242818
    [PubMed - as supplied by publisher]

    Related citations

    11.

    BCR-ABL activity measured by 50% inhibitory concentration for imatinib, p-CrkL/CrkL ratio or p-CrkL ratio in CD34+ cells of patients with chronic myeloid leukemia does not predict treatment response.

    Simara P, Peterkova M, Stejskal S, Potesilova M, Koutna I, Racil Z, Razga F, Jurcek T, Dvorakova D, Mayer J.

    Leuk Lymphoma. 2012 Mar 1. [Epub ahead of print] No abstract available.

    PMID:
    22233112
    [PubMed - as supplied by publisher]

    Related citations

    12.

    Intensive care unit management of patients with newly diagnosed acute myeloid leukemia with no organ failure.

    Lengliné E, Raffoux E, Lemiale V, Darmon M, Canet E, Boissel N, Schlemmer B, Dombret H, Azoulay E.

    Leuk Lymphoma. 2012 Feb 13. [Epub ahead of print]

    PMID:
    22233111
    [PubMed - as supplied by publisher]

    Related citations

    13.

    Immunoglobulin/T-cell receptor gene rearrangements in the diagnostic paradigm of pediatric patients with T-cell acute lymphoblastic leukemia.

    Kraszewska MD, Dawidowska M, Kosmalska M, Sędek L, Grzeszczak W, Szczepański T, Witt M.

    Leuk Lymphoma. 2012 Mar 16. [Epub ahead of print] No abstract available.

    PMID:
    22229792
    [PubMed - as supplied by publisher]

    Related citations

    14.

    p53 protein expression in chronic lymphocytic leukemia.

    Sellmann L, Carpinteiro A, Nückel H, Scholtysik R, Siemer D, Klein-Hipass L, Kube D, Dürig J, Dührsen U, Stanelle J, Küppers R.

    Leuk Lymphoma. 2012 Feb 13. [Epub ahead of print]

    PMID:
    22220854
    [PubMed - as supplied by publisher]

    Related citations

    15.

    Evolution of definitions of response, progression-free survival and event-free survival in front-line studies of chronic myeloid leukemia.

    Ansstas G, Vij R.

    Leuk Lymphoma. 2012 Feb 13. [Epub ahead of print]

    PMID:
    22220824
    [PubMed - as supplied by publisher]

    Related citations

    16.

    Functional polymorphisms in FAS, FASL and CASP8 genes and risk of childhood acute lymphoblastic leukemia: a case-control study.

    Tong N, Zhang L, Sheng X, Wang M, Zhang Z, Fang Y, Xue Y, Li J, Zhang Z.

    Leuk Lymphoma. 2012 Jan 31. [Epub ahead of print]

    PMID:
    22211869
    [PubMed - as supplied by publisher]

    Related citations

    17.

    Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib.

    Hayashi Y, Nakamae H, Katayama T, Nakane T, Koh H, Nakamae M, Hirose A, Hagihara K, Terada Y, Nakao Y, Hino M.

    Leuk Lymphoma. 2012 Jun;53(6):1084-9. Epub 2012 Jan 20.

    PMID:
    22211798
    [PubMed - in process]

    Related citations

    18.

    First-line treatment with imatinib mesylate in patients with chronic phase chronic myeloid leukemia: experience of a public hospital in a developing country of South America.

    da Silveira CA, Ferrari I.

    Leuk Lymphoma. 2012 Jan 31. [Epub ahead of print] No abstract available.

    PMID:
    22204455
    [PubMed - as supplied by publisher]

    Related citations

    19.

    No evidence for DNA methylation of the ATM promoter CpG island in chronic lymphocytic leukemia.

    Mikeska T, Carney DA, Seymour JF, Dobrovic A.

    Leuk Lymphoma. 2012 Jan 31. [Epub ahead of print] No abstract available.

    PMID:
    22204453
    [PubMed - as supplied by publisher]

    Related citations

    20.

    Long-term follow-up of patients with chronic myeloid leukemia in chronic phase developing sudden blast phase on imatinib therapy.

    Tantiworawit A, Power MM, Barnett MJ, Hogge DE, Nantel SH, Nevill TJ, Shepherd JD, Song KW, Sutherland HJ, Toze CL, Abou-Mourad YR, Narayanan S, Broady RC, Forrest DL.

    Leuk Lymphoma. 2012 Mar 5. [Epub ahead of print]

    PMID:
    22192245
    [PubMed - as supplied by publisher]

    Related citations

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk